Black Rock Inc. Casi Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$1.48 - $2.79 $1 - $2
1 Added 0.0%
91,715 $164,000
Q2 2022

Aug 12, 2022
BUY
$2.85 - $7.1 $261,384 - $651,169
91,714 New
91,714 $263,000

Others Institutions Holding CASI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CASI Pharmaceuticals, Inc.

CASI Quotes by TradingView
  • Ticker CASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,606,100
  • Market Cap $81.8M
  • Description
  • CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patien...
More about CASI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email